BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7906287)

  • 1. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma.
    Morges MA; Burton JH; Saba CF; Vail DM; Burgess KE; Thamm DH
    J Vet Intern Med; 2014; 28(5):1569-74. PubMed ID: 25274443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A canine cutaneous lymphoproliferative disorder resembling human mycosis fungoides.
    Shadduck JA
    Vet Clin North Am Small Anim Pract; 1979 Feb; 9(1):107-16. PubMed ID: 462704
    [No Abstract]   [Full Text] [Related]  

  • 5. TOX expression and role in CTCL.
    McGirt LY; Degesys CA; Johnson VE; Zic JA; Zwerner JP; Eischen CM
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1497-502. PubMed ID: 27345620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D in Cutaneous T-Cell Lymphoma.
    Ødum AF; Geisler C
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, tropism, and activity of cutavirus in circulating blood lymphocytes, stool, and skin biopsy specimens of patients with cutaneous T-cell lymphoma and parapsoriasis en plaques.
    Mohanraj U; Väkevä L; Ranki A; Söderlund-Venermo M
    J Med Virol; 2024 Apr; 96(4):e29575. PubMed ID: 38549497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosequencing applications in cutaneous T-cell lymphoma.
    Mandel J; Gleason L; Joffe D; Bhatti S; Nikbakht N
    Front Immunol; 2023; 14():1300061. PubMed ID: 38213330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description.
    D'Agostino P; Kent A; Sharp E; Schmidt F; Turini M
    Drugs Context; 2020; 9():. PubMed ID: 32821261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant T Cell Activation by a
    Dehner CA; Ruff WE; Greiling T; Pereira MS; Redanz S; McNiff J; Girardi M; Kriegel MA
    JID Innov; 2022 Mar; 2(2):100084. PubMed ID: 35199089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
    Lee M; Kistler C; Hartmann TB; Li F; Dummer R; Dippel E; Booken N; Klemke CD; Schadendorf D; Eichmüller SB
    Cancer Immunol Immunother; 2007 Jun; 56(6):783-95. PubMed ID: 17089123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops.
    Torii K; Okada Y; Morita A
    Sci Rep; 2021 Oct; 11(1):19629. PubMed ID: 34608214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-related increase in PIM2 expression in mycosis fungoides.
    Nielsen MH; Nielsen PR; Bzorek M; Eriksen JO; Wehkamp U; Lindahl LM; Woetmann A; Ødum N; Litman T; Gjerdrum LMR
    APMIS; 2024 May; ():. PubMed ID: 38757234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes.
    Almaani N; Farhan F; Bani Hamad S; Abuhawileh EA; Koubaitary L; Ahram M; Aladily TN
    J Int Med Res; 2024 Mar; 52(3):3000605241239034. PubMed ID: 38546260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma.
    Aran BM; Burton R; High WA; Gru AA
    J Cutan Pathol; 2024 May; ():. PubMed ID: 38725374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spindle cell cutaneous epitheliotropic T-cell lymphoma in an American Bulldog.
    Carpenter A; Aeschlimann K; Kuroki K
    J Comp Pathol; 2024 Apr; 210():1-4. PubMed ID: 38417247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.
    Gumina ME; Hooper MJ; Zhou XA; Koralov SB
    J Invest Dermatol; 2024 Apr; 144(4):755-763. PubMed ID: 38149950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Differences between Canine Cutaneous Epitheliotropic Lymphoma and Immune-Mediated Dermatoses.
    Gerber N; Brunner MAT; Jagannathan V; Leeb T; Gerhards NM; Welle MM; Dettwiler M
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33504055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Next top" mouse models advancing CTCL research.
    Luo Y; de Gruijl FR; Vermeer MH; Tensen CP
    Front Cell Dev Biol; 2024; 12():1372881. PubMed ID: 38665428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity of mycosis fungoides cells leads to the difficulties in determining tumour origin.
    Jin S; Zhao Y; Wang S; Wang P; Tang C; Zhu M; Wang P
    Australas J Dermatol; 2024 May; ():. PubMed ID: 38726851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.